Medtronic to pay $23.5M to settle kickback allegations; VertiFlex announces start of patient enrollment in study;

> Medtronic ($MDT) will to pay $23.5 million to settle allegations regarding kickbacks paid to doctors in post-market studies and device registries to implant its pacemakers and defibrillators. Item

> VertiFlex completes enrollment in its pivotal IDE clinical trial of the Superion interspinous spacer. The results of the Superion trial will form the basis for a PMA approval application to the FDA. VertiFlex release

> AngioScore reports the start of enrollment in the Drug-coated AngioSculpt Scoring Balloon Catheter First-in-Human Study. AngioScore release

> Health Canada gives marketing approval to Guided Therapeutics' LuViva advanced cervical scan. The company is in discussions with possible distributors in Canada and hopes the approval helps support regulatory efforts elsewhere. Guided Therapeutics release

> Mauna Kea Technologies ($MKEA) announces the publication of a new study on colorectal cancer in Gastrointestinal Endoscopy. The study results underline the value of Cellvizio's probe-based confocal laser endomicroscopy technology in the detection of residual neoplasia after colorectal endoscopic mucosal resection. Mauna Kea release

And Finally... There is a movement to encourage Congress to loosen restrictions on crowdfunding, the new capital-raising method that uses the Internet for startup investment--although the potential for fraud exists. Report